富蘭克林坦伯頓全球投資系列-生技領航基金A(acc)股
32.74美元0.48(1.49%)
2023/03/29更新
績效 / 1月1.07%
3月1.45%
1年3.9%
晨星評等 - 1.現金3.74%
- 2.股票11.52%
- 3.債券0.00%
- 4.其他84.74%
- 1.美國84.60%
- 2.英國5.09%
- 3.新興亞洲3.76%
- 4.歐元區1.40%
- 5.加拿大0.77%
- 1.Amgen Inc6.43%
- 2.Regeneron Pharmaceuticals Inc6.30%
- 3.Vertex Pharmaceuticals Inc6.20%
- 4.Gilead Sciences Inc5.70%
- 5.AstraZeneca PLC ADR4.56%
- 6.Jazz Pharmaceuticals PLC4.47%
- 7.Biogen Inc3.99%
- 8.Ascendis Pharma A/S ADR3.76%
- 9.Seagen Inc Ordinary Shares3.43%
- 10.PTC Therapeutics Inc3.42%
- 1.現金3.74%
- 2.股票11.52%
- 3.債券0.00%
- 4.其他84.74%
- 1.美國84.60%
- 2.英國5.09%
- 3.新興亞洲3.76%
- 4.歐元區1.40%
- 5.加拿大0.77%
- 1.Amgen Inc6.43%
- 2.Regeneron Pharmaceuticals Inc6.30%
- 3.Vertex Pharmaceuticals Inc6.20%
- 4.Gilead Sciences Inc5.70%
- 5.AstraZeneca PLC ADR4.56%
- 6.Jazz Pharmaceuticals PLC4.47%
- 7.Biogen Inc3.99%
- 8.Ascendis Pharma A/S ADR3.76%
- 9.Seagen Inc Ordinary Shares3.43%
- 10.PTC Therapeutics Inc3.42%